Abstract
Therapeutic apheresis is one of the key perioperative strategies for reduction of antibodies directed against donor antigens such as anti-ABO blood type antibody or anti-donor specific human leukocyte antigen (HLA) antibody. Simultaneous therapeutic apheresis can improve kidney survival in antibody mediated rejection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Takahashi K (2008) ABO-incompatible kidney transplantation: update. Nihon Jinzo Gakkaishi 50(7):880–886
Nishi S (2009) Jin-ishoku no subete. Medical View co Ltd, Tokyo, pp 80–81
Tanabe K (2006) Jin-ishoku no shinnpo wagakunino genjyou to kongo no tenbou. Tokyo igakusha, Tokyo, pp 101–110
Lee P, Zhu L, Terasaki PI et al (2009) Transplantation 88(4):568–574
Choy B, Chan T, Lai K (2006) Am J Transplant 6(11):2535–2542
Saito K, Nakagawa Y, Suwa M et al (2006) Xenotransplantation 13(2):111–117
Solez K, Colvin R, Racusen L et al (2007) Am J Transplant 7(3):518–526
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Japan
About this chapter
Cite this chapter
Kawarazaki, H. (2014). Living Related Kidney Transplantation. In: Noiri, E., Hanafusa, N. (eds) The Concise Manual of Apheresis Therapy. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54412-8_37
Download citation
DOI: https://doi.org/10.1007/978-4-431-54412-8_37
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54411-1
Online ISBN: 978-4-431-54412-8
eBook Packages: MedicineMedicine (R0)